Bioprocess technology for Antagonistic pseudomonas MCCB 102,103, micrococcus MCCB 104, and evaluation of synechocystis MCCB 114, 115 as prohibiotics for the management of ribrio in shrimp culture systems

Documents similaires

• Marine actinomycete NOCARDIOPSIS mccb 110 as source of novel drugs to manage vibriosis
  par: Sunish K S
  Publié: (2012)
• Bioprocess optimization and characterization of phytase from an environmental isolate bacillus MCCB 242
  par: Sareen Sarah John
• A marine actinomycete Nocardiopsis MCCB 110 as source of novel drugs to manage vibriosos
  par: Sunish.K.S
  Publié: (2012)
• Polyhydroxyalkanoates from Vibrio sp. MCCB 237: Isolation of the organism, medium optimization, polymer extraction and characterization
  par: Deepa S. Nair
  Publié: (2015)
• Sinful colours